Skip to main content

Animations

MJFF Publications

3021 - 3030 of 6433 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2024
  • 2022
  • 2024
  • Summary Details
    OPEN
    Title: A Smartphone Application as an Exploratory Endpoint in a Phase 3 Parkinson’s Disease Clinical Trial: A Pilot Study
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000521232
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00556-3
    Citation Count: 45
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-023-02843-5
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Locus specific endogenous retroviral expression associated with Alzheimer’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2023.1186470
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Cerebral chemoarchitecture shares organizational traits with brain structure and function
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.83843
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning Techniques
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms231810651
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Genetic Testing in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29500
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2313540121
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-021-00509-5
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Federated learning for multi-omics: A performance evaluation in Parkinson’s disease
    Journal Name: Patterns
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.patter.2024.100945
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.